Position in EXEL
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$21,491
+$4,550 QoQ
Shares Held
395
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 47 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ATWOOD & PALMER INC holds $54,515,898 across 9 Biotechnology names. EXEL ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,357 | $27,994,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,332 | $26,395,695 | |
| 3 | GALT |
Galectin Therapeutics Inc
|
10,000 | $46,400 | |
| 4 | SRPT |
Sarepta Therapeutics, Inc.
|
1,400 | $25,158 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
395 | $21,491 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,000 | $17,400 | |
| 7 | MNKD |
Mannkind Corp
|
2,000 | $8,520 | |
| 8 | MRNA |
Moderna, Inc.
|
100 | $7,003 |
All Filings in EXEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,491 | 395 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $16,941 | 395 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $17,312 | 395 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $16,313 | 395 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $17,411 | 395 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||